Let's be honest: the best news out of Pullman this week didn't come from the scoreboard. It came from a lab in the College of Veterinary Medicine, where researchers found a way to crank up your body's own virus fighters. That is a big deal. While we were all watching Three Cougs get the postgame mic after an Oregon State slugfest and shaking our heads at Lobos run wild as Cougs get smoked 92-64 in Albuquerque exhibition, a team here was quietly working on something that could change how we fight infections, cancer, even neurological disorders. That's the Wazzu we don't talk about enough.
Here's what happened. Professor Santanu Bose and his team, led by graduate students Lindsay Grace Miller and Sudiksha Pandit, figured out that a protein called ISG15 acts like a booster for your cells. When they cranked it up with a synthetic version, cells became significantly more resistant to viruses like RSV, influenza A, and parainfluenza. The key: this doesn't attack the virus itself. It strengthens the host cell. That means even if a virus mutates, this approach could still work. Bose said it plainly: "We're helping cells activate their own protective machinery." That's not just science talk. That's a potential shift in how we think about treatment.
What makes this worth a Coug's attention is the path from here. WSU's Innovation & Entrepreneurship team is already working on patent protection and has an active option to license the tech to a biotech company. That means this isn't just a paper in *Cell Communication and Signaling*, it's something with a real shot at becoming a therapeutic. And because the pathway also stimulates cellular events relevant to cancer and neurological disorders, the applications could stretch far beyond the flu. Bose is optimistic. We are too.
The takeaway is simple: while we watch the Cougs fight it out on the field, the real fight is happening in Pullman labs, and it's one we could all win. Watch for the next step from that biotech company. That's the score that matters.